The abstract is read at the publisher; the summary is JClub's.
Endothelial IDO1–dependent metabolic reprogramming is linked to BBB disruption and neurotoxicity in CAR-T-associated ICANS, with plasma IDO1 activity elevated in affected patients.
- Why it matters: The mechanisms connecting CAR-T inflammation to BBB breakdown in ICANS are unclear, limiting targeted strategies to prevent neurotoxicity.
- What they did: In a syngeneic CAR-T mouse model, endothelial IDO1 activation promoted endothelial activation, junctional protein loss, and barrier dysfunction; pharmacologic inhibition or endothelial-specific IDO1 silencing restored barrier integrity.
- The result: IDO1 redirected kynurenine metabolism toward KYNU-driven anthranilic acid production, disrupting Wnt/β-catenin tight junction maintenance and improving neurological outcomes when the pathway was blocked.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.